search
Back to results

Ethanol Locks for the Treatment of Central Venous Line Infections

Primary Purpose

Bloodstream Infection

Status
Terminated
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
70% ethanol
heparin flush solution
Sponsored by
Baystate Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Bloodstream Infection focused on measuring central line infection, 70% ethanol, Sepsis

Eligibility Criteria

6 Months - 23 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age 6 months-23 years
  • documented central line infection with bacteria or fungus (positive blood culture)

Exclusion Criteria:

  • allergy or intolerance to ethanol
  • pregnant or breastfeeding
  • central line tunnel or exit site infection

Sites / Locations

  • Baystate Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

1

2

Arm Description

70% ethanol lock solution instilled into central venous line of patient with documented infection, in addition to usual care with antimicrobials and supportive therapy. 70% ethanol solution dwells for 4 hours, then is withdrawn and discarded. This procedure repeated daily for 5 consecutive days.

heparin flush 10 units/ml lock solution instilled into central venous line of patient with documented infection, in addition to usual care with antimicrobials and supportive therapy. heparin flush solution dwells for 4 hours, then is withdrawn and discarded. This procedure repeated daily for 5 consecutive days.

Outcomes

Primary Outcome Measures

Clearance of Central Venous Line Infection by Day 6 of Study

Secondary Outcome Measures

Preservation of Central Venous Line (Line Not Requiring Removal) by Day 35 of Study
Recurrence of Central Venous Line Infection Within 35 Days of Enrollment

Full Information

First Posted
May 16, 2008
Last Updated
January 29, 2014
Sponsor
Baystate Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00680459
Brief Title
Ethanol Locks for the Treatment of Central Venous Line Infections
Official Title
Ethanol Locks for the Treatment of Central Venous Line Infections
Study Type
Interventional

2. Study Status

Record Verification Date
January 2014
Overall Recruitment Status
Terminated
Why Stopped
inability to enroll adequate number of patients
Study Start Date
May 2008 (undefined)
Primary Completion Date
June 2011 (Actual)
Study Completion Date
June 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Baystate Medical Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Ethanol Locks as an Adjunct Treatment for Central Venous Line Infections Purpose To evaluate the effectiveness of a 70% ethanol lock solution when used as an adjunct therapy with antibiotics to treat central venous line infections Study Design Randomized Controlled Trial Study Protocol Only those patients meeting all inclusion criteria and no exclusion criteria will be eligible to participate in this study. Once identified, signed informed consent will be obtained from the patient's guardian and the patient himself/herself depending on age. Patients will be randomized into 2 groups: Group 1 - those patients who will receive ethanol lock therapy and Group 2- those patients who will receive placebo therapy in the form of a heparin lock solution. Outcome Measures Treatment success as defined by- Clearance of the infection as documented by negative blood cultures on day 6 (one day after completed of lock treatment) Preservation of the line at 30 days post treatment (day 35 of the study), this will be documented by a chart review in CIS and telephone interview to ensure no further growth from blood cultures or infections Treatment failure as defined by- Clinical worsening during treatment Removal of the line due to persistent infection or sepsis Recurrence of infection with the same pathogen within 30 days
Detailed Description
Ethanol Lock Technique Protocol (adapted from the Children's Hospital Los Angeles) Obtain a 3ml syringe made by the Baystate Pharmacy which will contain either sterile 70% ethanol solution or 10 units/ml heparin flush solution. Randomization into study groups will be performed by the pharmacy in patient blocks of 10. Treating physician and nurses will be blinded to patient group assignment. Syringes will be labeled "70% ethanol/heparin lock Study Solution" Cleanse Hands Use aseptic Technique throughout procedure Clean injection cap/posi-flow cap with alcohol for 30 seconds and let dry Unclamp the catheter and gently flush with normal saline to ensure patency of the catheter Instill ethanol/heparin lock into the catheter to fill volume Broviac Single Lumen 4.2 Fr (ID 0.7) Dose 0.8ml Broviac Single Lumen 6.6 Fr (ID 1mm) Dose 0.8ml Med-comp Single Lumen Catheter Dose 1.2ml Hickman Double Lumen 7 Fr Distal (ID 1mm) Dose 1.2ml Hickman Double Lumen 9 Fr Proximal (ID 0.7) Dose 1.2ml Med-comp Double Lumen 8 or 10 Fr Dose 1.2ml Port-a-cath- Any Port (including priming tubing) Dose 1.9ml Clamp the catheter Label the locked lumen with the provided label so that med is not flushed through the catheter Let ethanol dwell in catheter continuously for 4 hours When ethanol has dwelled for 4 hours, withdraw and discard the lock solution The above procedure should be repeated daily for 5 consecutive days The above procedure should be repeated to each lumen of the central venous catheter daily if there are multiple lumens

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bloodstream Infection
Keywords
central line infection, 70% ethanol, Sepsis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
13 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
70% ethanol lock solution instilled into central venous line of patient with documented infection, in addition to usual care with antimicrobials and supportive therapy. 70% ethanol solution dwells for 4 hours, then is withdrawn and discarded. This procedure repeated daily for 5 consecutive days.
Arm Title
2
Arm Type
Placebo Comparator
Arm Description
heparin flush 10 units/ml lock solution instilled into central venous line of patient with documented infection, in addition to usual care with antimicrobials and supportive therapy. heparin flush solution dwells for 4 hours, then is withdrawn and discarded. This procedure repeated daily for 5 consecutive days.
Intervention Type
Drug
Intervention Name(s)
70% ethanol
Other Intervention Name(s)
alcohol
Intervention Description
70% ethanol lock solution instilled into central venous line of patient with documented infection, in addition to usual care with antimicrobials and supportive therapy. Volume of solution instilled varies from 0.8-1.9ml depending on volume of the lumen and hub of the particular size line being treated. 70% ethanol solution dwells for 4 hours, then is withdrawn and discarded. This procedure repeated daily for 5 consecutive days.
Intervention Type
Drug
Intervention Name(s)
heparin flush solution
Other Intervention Name(s)
anticoagulant
Intervention Description
heparin flush (10 units/ml) lock solution instilled into central venous line of patient with documented infection, in addition to usual care with antimicrobials and supportive therapy. Volume of solution instilled varies from 0.8-1.9ml depending on volume of the lumen and hub of the particular size line being treated. Heparin lock solution dwells for 4 hours, then is withdrawn and discarded. This procedure repeated daily for 5 consecutive days.
Primary Outcome Measure Information:
Title
Clearance of Central Venous Line Infection by Day 6 of Study
Time Frame
6 days
Secondary Outcome Measure Information:
Title
Preservation of Central Venous Line (Line Not Requiring Removal) by Day 35 of Study
Time Frame
35 days
Title
Recurrence of Central Venous Line Infection Within 35 Days of Enrollment
Time Frame
35 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
23 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age 6 months-23 years documented central line infection with bacteria or fungus (positive blood culture) Exclusion Criteria: allergy or intolerance to ethanol pregnant or breastfeeding central line tunnel or exit site infection
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christine A McKiernan, MD
Organizational Affiliation
Baystate Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Amanda Conti, MD
Organizational Affiliation
Baystate Medical Center
Official's Role
Study Director
Facility Information:
Facility Name
Baystate Medical Center
City
Springfield
State/Province
Massachusetts
ZIP/Postal Code
01199
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
17018464
Citation
Onland W, Shin CE, Fustar S, Rushing T, Wong WY. Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. Arch Pediatr Adolesc Med. 2006 Oct;160(10):1049-53. doi: 10.1001/archpedi.160.10.1049.
Results Reference
background

Learn more about this trial

Ethanol Locks for the Treatment of Central Venous Line Infections

We'll reach out to this number within 24 hrs